| FDA MedWatch
Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B)
Audience: Cosmetic surgeons, neurologists, consumers
08/04/2009 - FDA notified healthcare professionals of changes to the established drug names for Botox/Botox Cosmetic, Dysport and Myobloc to reinforce individual potencies and prevent medication errors, and provided recommendations for healthcare professionals to consider, plus information for patients, family members, and caregivers.
Read the complete MedWatch 2009 Safety summary including a link to the original alert and the update Information for Healthcare Professionals document, at:
http://www.fda.gov/Safety/MedWatch/SafetyInformation/
SafetyAlertsforHumanMedicalProducts/ucm164255.htm
|
|